FacebookTwitterGoogle+RedditEmail

Here Come the FrankenSalmon

The U.S. Food and Drug Administration (FDA) may soon approve the sale of genetically engineered (GE) salmon to American consumers. Incredibly, the FDA may do so without requiring that the fish be labeled as genetically engineered.

Marion Nestle, a professor in the Nutrition, Food Studies and Public Health Department at New York University has said, “The public wants to know and the public has a right to know. I think the agency has discretion, but it’s under enormous political pressure to approve [the salmon] without labeling.”

Misleading Shoppers as a Sales Strategy?

Wild salmon delivers tremendous nutritional benefits, but the possible action by the FDA could lead shoppers seeking healthy food for their families to unknowingly buy a GE substitute. Scientists have cautioned that there has been insufficient study of its impact on human health and the environment.

The nonprofit Union of Concerned Scientists states on its web site:

“So far, scientists have identified a number of ways in which genetically engineered organisms could potentially adversely impact both human health and the environment…In addition to posing risks of harm that we can envision and attempt to assess, genetic engineering may also pose risks that we simply do not know enough to identify.”

After submitting a Freedom of Information Act request, the consumer advocacy group Food & Water Watch received numerous recent internal documents and emails from the U.S. Department of Interior’s Fish & Wildlife Service (FWS) exposing startling concerns about the GE salmon for which the company AquaBounty is seeking approval.

“Nice work Greg,” Denise Hawkins, PhD, FWS Regional Geneticist wrote to a coworker in September. “Especially pointing out that there is no data to support the claims of low survival in the event of escape, which I agree with you all is a big concern. I also agree…that using triploid fish [which AquaBounty claim have undergone a sterilization process] is not foolproof. Maybe they [the FDA] should watch Jurassic Park.”

A Very Real Threat to Wild Salmon

The FDA is required by law to conduct an environmental impact statement for any regulatory action that could negatively affect the human environment. The agency has not done so yet. Despite AquaBounty’s claim to produce only sterile salmon, the company admitted that up to 5% of their GE salmon eggs could be fertile, prompting the FDA to label the company’s claims “potentially misleading”.

According to FWS internal emails, contrary to AquaBounty’s claims that GE salmon would be grown in closed systems (and therefore unable to escape), FWS employees received news of a proposal to grow the fish in a facility that would discharge into the ocean off the coast of Maine.

“No matter what precautions you take, fish escape and once they do, there is no closing that door. So, that being said, I think it is very bad precedent to set,” said one FWS program supervisor.

The FDA is closing a public comment period on November 22nd and could approve the product as soon as November 23rd.

JEFF DEASY is the founder of American Feast. He can be reached at: jdeasy@americanfeast.com

 

More articles by:

Weekend Edition
January 18, 2019
Friday - Sunday
Melvin Goodman
Star Wars Revisited: One More Nightmare From Trump
John Davis
“Weather Terrorism:” a National Emergency
Jeffrey St. Clair
Roaming Charges: Sometimes an Establishment Hack is Just What You Need
Joshua Frank
Montana Public Schools Block Pro-LGBTQ Websites
Louisa Willcox
Sky Bears, Earth Bears: Finding and Losing True North
Robert Fisk
Bernie Sanders, Israel and the Middle East
Robert Fantina
Pompeo, the U.S. and Iran
David Rosen
The Biden Band-Aid: Will Democrats Contain the Insurgency?
Nick Pemberton
Human Trafficking Should Be Illegal
Steve Early - Suzanne Gordon
Did Donald Get The Memo? Trump’s VA Secretary Denounces ‘Veteran as Victim’ Stereotyping
Andrew Levine
The Tulsi Gabbard Factor
John W. Whitehead
The Danger Within: Border Patrol is Turning America into a Constitution-Free Zone
Dana E. Abizaid
Kafka’s Grave: a Pilgrimage in Prague
Rebecca Lee
Punishment Through Humiliation: Justice For Sexual Assault Survivors
Dahr Jamail
A Planet in Crisis: The Heat’s On Us
John Feffer
Trump Punts on Syria: The Forever War is Far From Over
Dave Lindorff
Shut Down the War Machine!
Glenn Sacks
LA Teachers’ Strike: Student Voices of the Los Angeles Education Revolt  
Mark Ashwill
The Metamorphosis of International Students Into Honorary US Nationalists: a View from Viet Nam
Ramzy Baroud
The Moral Travesty of Israel Seeking Arab, Iranian Money for its Alleged Nakba
Ron Jacobs
Allen Ginsberg Takes a Trip
Jake Johnston
Haiti by the Numbers
Binoy Kampmark
No-Confidence Survivor: Theresa May and Brexit
Victor Grossman
Red Flowers for Rosa and Karl
Cesar Chelala
President Donald Trump’s “Magical Realism”
Christopher Brauchli
An Education in Fraud
Paul Bentley
The Death Penalty for Canada’s Foreign Policy?
David Swanson
Top 10 Reasons Not to Love NATO
Louis Proyect
Breaking the Left’s Gay Taboo
Kani Xulam
A Saudi Teen and Freedom’s Shining Moment
Ralph Nader
Bar Barr or Regret this Dictatorial Attorney General
Jessicah Pierre
A Dream Deferred: MLK’s Dream of Economic Justice is Far From Reality
Edward J. Martin
Glossip v. Gross, the Eighth Amendment and the Torture Court of the United States
Chuck Collins
Shutdown Expands the Ranks of the “Underwater Nation”
Paul Edwards
War Whores
Peter Crowley
Outsourcing Still Affects Us: This and AI Worker Displacement Need Not be Inevitable
Alycee Lane
Trump’s Federal Government Shutdown and Unpaid Dishwashers
Martha Rosenberg
New Questions About Ritual Slaughter as Belgium Bans the Practice
Wim Laven
The Annual Whitewashing of Martin Luther King Jr.
Nicky Reid
Panarchy as Full Spectrum Intersectionality
Jill Richardson
Hollywood’s Fat Shaming is Getting Old
Nyla Ali Khan
A Woman’s Wide Sphere of Influence Within Folklore and Social Practices
Richard Klin
Dial Israel: Amos Oz, 1939-2018
David Rovics
Of Triggers and Bullets
David Yearsley
Bass on Top: the Genius of Paul Chambers
FacebookTwitterGoogle+RedditEmail